CTRI/2025/12/098345尚未招募不适用
Cell free DNA as markers of malignancy in thyroid nodules
Dr Smita Sonoli1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2025年12月13日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- To detect thyroid malignancies at an early stage, improving treatment outcomes and patient survival rates
研究概览
简要总结
Introduction Thyroid malignancy is the most common endocrine malignancy which usually presents as a solitary thyroid nodule. Studies have suggested that 5 percent to 15 percent of all thyroid nodules evaluated are malignant. We propose to differentiate malignant from benign thyroid nodules by quantification of plasma cell free DNA.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 80.00 Year(s)（—）
- 性别
- All
入选标准
- •Consecutive patients attending the endocrinology OPD.
排除标准
- •Hyperthyroidism with multi nodular disease on ultrasonography.
- •Anaplastic cancer and medullary thyroid cancer.
- •Patients with past/current history of any known malignancies.
结局指标
主要结局
To detect thyroid malignancies at an early stage, improving treatment outcomes and patient survival rates
时间窗: 8 weeks
次要结局
未报告次要终点
研究者
Dr Smita Sonoli
KAHER Jawaharlal Nehru Medical College
研究点 (1)
Loading locations...
相似试验
招募中
不适用
ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial CancerNCT07270666Memorial Sloan Kettering Cancer Center30
尚未招募
不适用
Testing blood markers to check gum health in smokers and non-smokers.CTRI/2025/08/093243Dr Sruthy Sudir60
招募中
不适用
Feasibility of Circulating Tumour DNA (ctDNA) Analysis Using Automated Capillary Blood SamplingNCT07310537Erasmus Medical Center35
尚未招募
不适用
Detecting Rare Cancer Cells and DNA in blood samples of Early-Stage Triple-Negative Breast Cancer After ChemotherapyCTRI/2024/12/078366OneCell Diagnostics50
尚未招募
不适用
Clinical Utility of ctDNA in the Treatment of Oligometastatic DiseaseNCT07426250Aarhus University Hospital500